Vaccines, blood, antisera, toxins and cultures in   Slovenia

Exports In 2022, Slovenia exported $1.2B in Vaccines, blood, antisera, toxins and cultures, making it the 22nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in Slovenia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Slovenia are: Russia ($255M), Switzerland ($220M), Germany ($197M), Croatia ($57.4M), and Serbia ($43.4M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Slovenia between 2021 and 2022 were Russia ($221M), Croatia ($25.3M), and Lithuania ($22.6M).

Imports In 2022, Slovenia imported $1.04B in Vaccines, blood, antisera, toxins and cultures, becoming the 37th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Slovenia. Slovenia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($453M), United States ($131M), Germany ($128M), Ireland ($99.1M), and Hungary ($53.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Slovenia between 2021 and 2022 were United States ($87.4M), France ($41.7M), and Hungary ($17.5M).